Cameron Turtle

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Waltham, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Heidy King-Jones, as Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Cameron Turtle

Form 4 holding Director

Oruka Therapeutics, Inc.

Security class
Common Stock
Shares / value
85,233
Estimated value
$253,722
Report date
29 Aug 2024
Price
$2.98
Ownership
By Turtle Family Trust
Form 4 holding Chief Executive Officer, Director

Spyre Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
528,000
Estimated value
Report date
09 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Cameron Turtle

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .